[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:asthma:ige":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Asthma","IgE",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06372249","A Clinical Trial of Soluble Fiber for Asthma",[12],"Phase 2","RECRUITING","2026-08-26T02:17:26.640202Z","2026-05-05T02:43:28.121144Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05332067","Omalizumab Before Onset of Exacerbations",[12],"2026-08-26T02:19:08.862440Z","2026-04-29T02:57:57.107344Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT06191315","Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma\u002FAsthmatic Wheeze Aged 2 to \u003C6 Years (LIBERTY ASTHMA TREKIDS)",[26],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:15:44.309045Z","2026-05-05T02:43:28.848498Z"]